|
Volumn 22, Issue 2, 2012, Pages 270-272
|
Does treatment of metabolic syndrome components improve psoriasis? Report of three cases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
CHOLESTEROL;
EMOLLIENT AGENT;
GLIBENCLAMIDE;
HEMOGLOBIN A1C;
HYDROCHLOROTHIAZIDE;
LOSARTAN;
METFORMIN;
RAMIPRIL;
TRIACYLGLYCEROL;
ADULT;
CASE REPORT;
CHOLESTEROL BLOOD LEVEL;
COMORBIDITY;
DIET THERAPY;
DISEASE ASSOCIATION;
DISEASE CONTROL;
DISEASE SEVERITY;
FEMALE;
GLYCEMIC CONTROL;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
HYPERTRIGLYCERIDEMIA;
LETTER;
MALE;
METABOLIC SYNDROME X;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
PSORIASIS;
RISK FACTOR;
SKIN DEFECT;
TREATMENT FAILURE;
TREATMENT RESPONSE;
TRIACYLGLYCEROL BLOOD LEVEL;
WEIGHT REDUCTION;
ADULT;
BODY MASS INDEX;
CHOLESTEROL;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
MALE;
METABOLIC SYNDROME X;
MIDDLE AGED;
PSORIASIS;
SEVERITY OF ILLNESS INDEX;
|
EID: 84859736241
PISSN: 11671122
EISSN: 19524013
Source Type: Journal
DOI: 10.1684/ejd.2011.1614 Document Type: Letter |
Times cited : (5)
|
References (6)
|